Frontlight ResearchEarly access
Neuroendocrine tumours trials in Canada
5 of 16 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in CanadaA Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
- Where
- Vancouver
- Age
- 18 years and over
- People
- 60
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT07621146 - No phaseTaking peopleNon-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
- Where
- Toronto
- Age
- 18 years and over
- People
- 800
- Run by
- University Health Network, Toronto
See details and how to joinNCT05196087 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - No phaseTaking peopleLife Following Excision of Neuroendocrine Tumors
- Where
- Toronto
- Age
- 18 years and over
- People
- 246
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT06981455 - No phaseTaking people68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
- Where
- Calgary
- Age
- 18 years to 100 years
- People
- 500
- Run by
- Alberta Health services
See details and how to joinNCT05673031